Log in

NASDAQ:MRSNMersana Therapeutics News Headlines

$20.47
-0.34 (-1.63 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$20.35
Now: $20.47
$21.04
50-Day Range
$19.88
MA: $21.52
$23.40
52-Week Range
$1.32
Now: $20.47
$24.97
Volume539,161 shs
Average Volume655,348 shs
Market Capitalization$1.37 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.64

Headlines

Mersana Therapeutics (NASDAQ MRSN) News Headlines

Source:
DateHeadline
Mersana Therapeutics (NASDAQ:MRSN) Lifted to Buy at ValuEngineMersana Therapeutics (NASDAQ:MRSN) Lifted to Buy at ValuEngine
marketbeat.com - August 4 at 1:07 AM
Mersana Therapeutics (NASDAQ:MRSN) Shares Gap Up  After Analyst UpgradeMersana Therapeutics (NASDAQ:MRSN) Shares Gap Up After Analyst Upgrade
marketbeat.com - May 28 at 1:38 PM
Mersana Therapeutics Inc (NASDAQ:MRSN) Given Consensus Recommendation of "Buy" by BrokeragesMersana Therapeutics Inc (NASDAQ:MRSN) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - August 7 at 4:46 AM
Earnings Preview for Mersana TherapeuticsEarnings Preview for Mersana Therapeutics
finance.yahoo.com - August 6 at 11:07 PM
Are Institutions Heavily Invested In Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) Shares?Are Institutions Heavily Invested In Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) Shares?
finance.yahoo.com - August 4 at 1:20 PM
Mersana Therapeutics (MRSN) Scheduled to Post Earnings on FridayMersana Therapeutics (MRSN) Scheduled to Post Earnings on Friday
www.americanbankingnews.com - August 1 at 11:10 PM
Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2020 Financial Results and Business UpdatesMersana Therapeutics to Host Conference Call Announcing Second Quarter 2020 Financial Results and Business Updates
finance.yahoo.com - July 31 at 8:27 AM
 Analysts Expect Mersana Therapeutics Inc (NASDAQ:MRSN) Will Announce Quarterly Sales of $430,000.00 Analysts Expect Mersana Therapeutics Inc (NASDAQ:MRSN) Will Announce Quarterly Sales of $430,000.00
www.americanbankingnews.com - July 19 at 2:12 AM
Mersana Therapeutics Sees Unusually Large Options Volume (NASDAQ:MRSN)Mersana Therapeutics Sees Unusually Large Options Volume (NASDAQ:MRSN)
www.americanbankingnews.com - July 17 at 3:18 PM
Mersana Therapeutics Inc (NASDAQ:MRSN) Expected to Announce Earnings of -$0.30 Per ShareMersana Therapeutics Inc (NASDAQ:MRSN) Expected to Announce Earnings of -$0.30 Per Share
www.americanbankingnews.com - July 17 at 12:44 PM
Mersana Therapeutics Inc (NASDAQ:MRSN) Given Average Recommendation of "Buy" by BrokeragesMersana Therapeutics Inc (NASDAQ:MRSN) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 13 at 3:30 AM
Stoke Therapeutics Announces Publication of Data in the Journal Nature Communications That Support the Company’s Proprietary Approach to Addressing Severe Genetic Diseases by Precisely Upregulating Protein ExpressionStoke Therapeutics Announces Publication of Data in the Journal Nature Communications That Support the Company’s Proprietary Approach to Addressing Severe Genetic Diseases by Precisely Upregulating Protein Expression
finance.yahoo.com - July 9 at 9:02 AM
Here is What Hedge Funds Think About Stoke Therapeutics, Inc. (STOK)Here is What Hedge Funds Think About Stoke Therapeutics, Inc. (STOK)
finance.yahoo.com - July 8 at 5:32 PM
Mersana Therapeutics, Inc.Mersana Therapeutics, Inc.
www.fool.com - July 3 at 10:49 PM
Mersanas Shares March Higher, Can It Continue?Mersana's Shares March Higher, Can It Continue?
www.nasdaq.com - June 26 at 12:26 PM
Mersana's Shares March Higher, Can It Continue?Mersana's Shares March Higher, Can It Continue?
finance.yahoo.com - June 26 at 12:26 PM
Stock Alert: Mersana At New HighStock Alert: Mersana At New High
www.nasdaq.com - June 23 at 3:11 PM
Mersana Therapeutics XMT-1592 shows positive action in early-stage studyMersana Therapeutics' XMT-1592 shows positive action in early-stage study
seekingalpha.com - June 22 at 1:34 PM
Mersana Therapeutics Presents Preclinical Data from its Innovative Dolasynthen and Immunosynthen ADC Platforms at American Association for Cancer Research 2020 Virtual Annual MeetingMersana Therapeutics Presents Preclinical Data from its Innovative Dolasynthen and Immunosynthen ADC Platforms at American Association for Cancer Research 2020 Virtual Annual Meeting
finance.yahoo.com - June 22 at 1:34 PM
Got $1,000? Buy These 4 Cancer StocksGot $1,000? Buy These 4 Cancer Stocks
finance.yahoo.com - June 8 at 2:10 PM
Stoke Therapeutics Appoints Julie Anne Smith to its Board of DirectorsStoke Therapeutics Appoints Julie Anne Smith to its Board of Directors
finance.yahoo.com - June 4 at 9:12 AM
Why Mersana Therapeutics (MRSN) Could Be Positioned for a SurgeWhy Mersana Therapeutics (MRSN) Could Be Positioned for a Surge
finance.yahoo.com - June 4 at 9:12 AM
Stock Alert: Mersana Shares Hit New 52-Week HighStock Alert: Mersana Shares Hit New 52-Week High
www.nasdaq.com - June 1 at 7:18 AM
Mersana Therapeutics (MRSN) Presents At ASCO 2020 - SlideshowMersana Therapeutics (MRSN) Presents At ASCO 2020 - Slideshow
seekingalpha.com - May 29 at 6:05 PM
Mersana Therapeutics (MRSN) in Focus: Stock Moves 8.3% HigherMersana Therapeutics (MRSN) in Focus: Stock Moves 8.3% Higher
finance.yahoo.com - May 29 at 1:04 PM
Mersana Therapeutics prices equity offeringMersana Therapeutics prices equity offering
seekingalpha.com - May 29 at 8:03 AM
Why Mersana Therapeutics (MRSN) Stock Might be a Great Pick?Why Mersana Therapeutics (MRSN) Stock Might be a Great Pick?
www.nasdaq.com - May 28 at 2:38 PM
Clinical Studies & Research Progressing for Finding Cure for GlioblastomaClinical Studies & Research Progressing for Finding Cure for Glioblastoma
www.prnewswire.com - May 28 at 9:37 AM
Thinking about trading stocks or options in Dollar Tree, Boeing, Novavax, Norwegian Cruise Line, or Mersana Therapeutics?Thinking about trading stocks or options in Dollar Tree, Boeing, Novavax, Norwegian Cruise Line, or Mersana Therapeutics?
www.benzinga.com - May 28 at 9:37 AM
Why Mersana Therapeutics (MRSN) Spiked 69% TodayWhy Mersana Therapeutics (MRSN) Spiked 69% Today
finance.yahoo.com - May 27 at 10:23 PM
P/E Ratio Insights for Mersana TherapeuticsP/E Ratio Insights for Mersana Therapeutics
www.benzinga.com - May 27 at 5:22 PM
Why Mersana Therapeuticss Stock Is Trading Higher TodayWhy Mersana Therapeutics's Stock Is Trading Higher Today
www.benzinga.com - May 27 at 5:22 PM
Mid-Day Market Update: Crude Oil Falls Over 5%; Mersana Therapeutics Shares JumpMid-Day Market Update: Crude Oil Falls Over 5%; Mersana Therapeutics Shares Jump
www.benzinga.com - May 27 at 12:22 PM
Why Mersanas Cancer Study Is HugeWhy Mersana's Cancer Study Is Huge
247wallst.com - May 27 at 12:22 PM
Mersanas XMT-1536 shows positive action in ovarian cancerMersana's XMT-1536 shows positive action in ovarian cancer
seekingalpha.com - May 27 at 12:22 PM
Stock Alert: Mersana Therapeutics Up 30% On Positive Data Of Cancer DrugStock Alert: Mersana Therapeutics Up 30% On Positive Data Of Cancer Drug
www.nasdaq.com - May 27 at 12:22 PM
Why Mersana Therapeutics Stock Is Skyrocketing TodayWhy Mersana Therapeutics Stock Is Skyrocketing Today
finance.yahoo.com - May 27 at 12:22 PM
Mersana Therapeutics Reports Positive Interim Data from the Expansion Portion of the XMT-1536 Phase 1 StudyMersana Therapeutics Reports Positive Interim Data from the Expansion Portion of the XMT-1536 Phase 1 Study
finance.yahoo.com - May 27 at 7:22 AM
Mulling Over Mersana TherapeuticsMulling Over Mersana Therapeutics
seekingalpha.com - May 23 at 12:01 AM
Mersana Therapeutics to Present Two Posters at the American Association for Cancer Research 2020 Virtual Annual MeetingMersana Therapeutics to Present Two Posters at the American Association for Cancer Research 2020 Virtual Annual Meeting
finance.yahoo.com - May 15 at 8:28 AM
Mersana Therapeutics Announces Initiation of XMT-1592 Phase 1 Dose Escalation StudyMersana Therapeutics Announces Initiation of XMT-1592 Phase 1 Dose Escalation Study
finance.yahoo.com - May 14 at 5:20 PM
BRIEF-Mersana Therapeutics To Present Interim Data From Phase 1 Expansion Of XMT-1536 At ASCO 2020 Virtual Scientific ProgramBRIEF-Mersana Therapeutics To Present Interim Data From Phase 1 Expansion Of XMT-1536 At ASCO 2020 Virtual Scientific Program
www.reuters.com - May 13 at 9:13 PM
Mersana Therapeutics to Present Interim Data from Phase 1 Expansion of XMT-1536 at the American Society of Clinical Oncology 2020 Virtual Scientific ProgramMersana Therapeutics to Present Interim Data from Phase 1 Expansion of XMT-1536 at the American Society of Clinical Oncology 2020 Virtual Scientific Program
finance.yahoo.com - May 13 at 9:13 PM
Mersana Therapeutics to Report Interim Data from Phase 1 Dose Expansion of XMT-1536Mersana Therapeutics to Report Interim Data from Phase 1 Dose Expansion of XMT-1536
finance.yahoo.com - May 13 at 8:33 AM
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Analysts Are Pretty Bullish On The Stock After Recent ResultsMersana Therapeutics, Inc. (NASDAQ:MRSN) Analysts Are Pretty Bullish On The Stock After Recent Results
finance.yahoo.com - May 12 at 5:31 PM
H.C. Wainwright Sticks to Their Buy Rating for Mersana Therapeutics IncH.C. Wainwright Sticks to Their Buy Rating for Mersana Therapeutics Inc
finance.yahoo.com - May 11 at 4:49 PM
Mersana Therapeutics, Inc. (MRSN) Q1 2020 Earnings Call TranscriptMersana Therapeutics, Inc. (MRSN) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 10 at 12:30 AM
BRIEF-Mersana Therapeutics Files For Mixed Shelf Of Upto $250 MillionBRIEF-Mersana Therapeutics Files For Mixed Shelf Of Upto $250 Million
www.reuters.com - May 8 at 8:46 PM
Mersana Therapeutics (MRSN) CEO Anna Protopapas on Q1 2020 Results - Earnings Call TranscriptMersana Therapeutics' (MRSN) CEO Anna Protopapas on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 3:46 PM
Recap: Mersana Therapeutics Q1 EarningsRecap: Mersana Therapeutics Q1 Earnings
finance.yahoo.com - May 8 at 3:46 PM
Mersana Therapeutics EPS beats by $0.02, misses on revenueMersana Therapeutics EPS beats by $0.02, misses on revenue
seekingalpha.com - May 8 at 8:00 AM
Mersana Therapeutics Announces First Quarter 2020 Financial Results and Provides Business UpdateMersana Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - May 8 at 8:00 AM
This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.